Related Experiment Video
Updated: Jun 5, 2026

Systemic and Local Drug Delivery for Treating Diseases of the Central Nervous System in Rodent Models
Published on: August 16, 2010
Synthetic Vesicle-Based Drug Delivery Systems for Oral Disease Therapy: Current Applications and Future Directions
Pengjie Huang1, Weichang Li1, Jiezhong Guan1
1Hospital of Stomatology, Guanghua School of Stomatology, Guangdong Provincial Key Laboratory of Stomatology, Sun Yat-sen University, Guangzhou 510055, China.
Novel drug delivery systems using liposomes, polymersomes, and extracellular vesicles (EVs) show promise for treating oral diseases like caries and periodontitis, potentially overcoming limitations of traditional therapies.
Area of Science:
- Biomedical Engineering
- Nanotechnology
- Oral Health
Background:
- Oral diseases, including dental caries, periodontitis, and oral cancer, pose significant global public health challenges.
- Current treatments often require postoperative drug therapy, which faces limitations like poor drug penetration, side effects, and drug resistance.
Purpose of the Study:
- To review and analyze the potential of drug-loaded vesicles (liposomes, polymersomes, extracellular vesicles) for enhanced oral disease treatment.
- To explore the characteristics, advantages, limitations, and optimization strategies of these vesicle-based drug delivery systems.
Main Methods:
- Comprehensive literature review on liposomes, polymersomes, and extracellular vesicles in oral disease therapy.
- Analysis of drug encapsulation efficiency, controlled release, and biocompatibility of different vesicle types.
- Examination of clinical applications, development prospects, and optimization strategies.
Main Results:
- Drug-loaded vesicles offer high encapsulation efficiency, controlled release, and excellent biocompatibility, addressing limitations of traditional oral disease treatments.
- Liposomes, polymersomes, and extracellular vesicles demonstrate unique characteristics and potential for improved therapeutic efficacy.
- Specific applications and optimization strategies are discussed for enhancing clinical outcomes.
Conclusions:
- Vesicle-based drug delivery systems represent a promising frontier for advancing oral disease treatment.
- Further research and optimization are needed to fully realize the clinical potential of these advanced therapeutic platforms.
Related Concept Videos
Routes of Drug Administration: Enteral
Enteral administration involves drug administration via the mouth in two ways: orally or sublingually.
Unlike sublingually drugs, drugs that are taken orally pass through the gastrointestinal (GI) tract and get metabolized by the liver. Once metabolized, the drug is absorbed into the systemic circulation, reaching different body parts via the bloodstream. However, while passing through the stomach,...
Routes of Drug Administration: Overview
Enteral administration refers to drugs absorbed through the gastrointestinal tract. They can be swallowed (perorally), placed under the tongue (sublingually), or on the inner lining of the cheeks (buccally). Perorally administered drugs take time to be absorbed and have a slower onset of action. The rectal route is another form of enteral administration, which allows for...
Drug Delivery: Overview
Enteral delivery involves administering drugs directly through swallowing, sublingual placement, or buccal application. Orally administered drugs predominantly navigate the...
Drug Delivery: Enteral Route
Drug Delivery: Miscellaneous Routes
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs...
Factors Affecting Dissolution: Particle Size and Effective Surface Area

